GlassScriptPhysician profile
Charles Camisa
NPI 1376596908
$58,824.97
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $13K · 2021: $17K · 2022: $1,759 · 2023: $123 · 2024: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $411.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $33,091.63 | 2019-2022 | |
| Celgene Corporation | $17,053.76 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $4,988.92 | 2019 | |
| Abbvie INC. | $1,145.08 | 2019-2024 | |
| Sun Pharmaceutical Industries INC. | $533.24 | 2019-2024 | |
| Lilly USA, LLC | $305.43 | 2019-2021 | |
| Janssen Biotech, INC. | $291.59 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $276.90 | 2019-2021 | |
| Genzyme Corporation | $203.80 | 2019-2024 | |
| Incyte Corporation | $198.12 | 2022 | |
| Vyne Pharmaceuticals INC. | $181.34 | 2020 | |
| Dermira, INC. | $145.86 | 2019-2021 | |
| Dermavant Sciences, INC. | $123.26 | 2023 | Vtama |
| Leo Pharma INC. | $100.57 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $77.48 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $30.21 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.05 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $19.73 | 2019 | |
| Pfizer INC. | $17.33 | 2020 | |
| Aclaris Therapeutics, INC. | $16.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Camisa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.